from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3790/dprE1

LFCtreatmentdescriptionclass of inhibitor

-0.855

Amikacinug/mL Amikacintranslation

1.155

Cap5-10ug/mL Capreomycintranslation

0.781

Rox10-50 ug/mL Roxithromycintranslation

0.812

SM2-5 ug/mL Streptomycintranslation

-1.398

Tet5-10 ug/mL Tetracyclinetranslation

-0.895

Rif0.2-5ug/mL Rifampicintranscription

0.789

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.481

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.181

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.284

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.638

Clofazimine10-13 ug/mL Clofaziminerespiration

0.471

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.158

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.550

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.304

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.860

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.670

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.247

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.608

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.984

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

1.474

Nigericin50 uM Nigericinrespiration

-0.447

TRC10-150 ug/mL Triclosanrespiration

-0.784

TRZ10-25 ug/mL Thioridazinerespiration

-1.085

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.327

menadione6-10 ug/mL Menadionerespiration

0.272

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.626

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.472

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.050

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.042

NRP_1Non-replicating persistence stage 1dosRassociated

0.606

Amp0.2mg/mL AmpicillincellWall

0.725

Cephalexin20-100 ug/mL CephalexincellWall

0.872

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.398

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.115

EMB10-20 ug/mL EthambutolcellWall

0.836

Eta12-40 ug/mL EthionamidecellWall

0.795

INH0.2-0.4 ug/mL IsoniazidcellWall

0.371

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.667

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.206

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.321

BZA0.12 mg/mL BenzamidearomaticAmides

0.047

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.314

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.393

H2O24 mM hydrogen peroxideDNAdamaging

1.353

Levo10 ug/mL LevofloxacinDNAdamaging

0.578

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.138

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.165

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.342

UVUV-irradiationDNAdamaging

-0.136

ARP41-4 ug/mL Antitubercular compound ARP4?

0.252

Antimycin12.5-50 ug/mL Antimycin A?

0.919

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.410

PA_110-50 ug/mL Antitubercular compound PA-1?

0.349

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.512

PA8240.2-2 ug/mL PA-824?

-1.440

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.310

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.452

Verapamil50 uM Verapamil?

0.249

mercaptoethanol2 mM 2-Mercaptoethanol?

0.973

methoxatin10-20 ug/mL Methoxatin?